Cite
HARVARD Citation
Simmonds, N. et al. (n.d.). S70 Clinical effectiveness results from the first interim analysis of the VOCAL study; an observational study of ivacaftor in patients with cystic fibrosis and selected non-G551D gating mutations. Thorax. p. A43. [Online].